Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a98:c004:0:b0:1eb:e128:bbe3 with SMTP id l4csp3962040eic;
        Mon, 15 Jan 2024 14:28:19 -0800 (PST)
X-Google-Smtp-Source: AGHT+IGZwHqO46CSLrPwrYvu/QzFxuG33bWJHcSPdYN8L07A2mdLx1T6PhGO0UhSAvf1ZnbFRacf
X-Received: by 2002:a17:902:6e08:b0:1d4:419c:3c86 with SMTP id u8-20020a1709026e0800b001d4419c3c86mr6504589plk.82.1705357699427;
        Mon, 15 Jan 2024 14:28:19 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705357699; cv=none;
        d=google.com; s=arc-20160816;
        b=ri7KP2ePQR1MGcNZA5mFXnG4UfOnvw16LY+iomOZ48bgWrtjHrEWpKiHzjTEM5tBoD
         tvQhsEqi9AZfyZAY4hWRT6lfJ6wKSdnGbyRxQ5tX0bC5OY4EZElFrEovuWdP5dcyqE7X
         M2okSrY3JOm8n/xLP7f9pLdHeAdGmOjJlb5F3GSQocDn2hfKPLl8o9cg/72njaaIBgbE
         joG0F18BlOYGcJKdeU3P/N9YTwC8JDKBFPgvyk/vybyggKWV60ASYWQS81ylcZCj7mH6
         1p0poNdl3l5PVwCvKqCeIUChxqBucbjkOozAV4Pn40Ae8aUeI7cb6p6O0j8HnSCealHd
         SZRA==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=huwX6AGmo69Ffsg0k8FOCJ5d41UGUjQc1m6pfM52pYA=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=HJbQt1JU/pTTJtzGBzBQqD7bkWaqPR8u3X4FKkrXu/rIEX3M5mvjtFAbTzIO/jlIa1
         q19GwdXgmhWPmPD0Kh0G1KaeJV1VB7fLn6QSftL4Fk9YatXgQ0UPhSS2MtvnPAL+UQEI
         WxxEO9qz5b8FR2kvZkpYgWbx7qAyjdjOwlxJG+ev8Mz2OP6nuA+Ku46PeZT4eSxWSisG
         2PwJqLB8FJih7gAGT1Oel4ndcUgvvylhhEJu04bBsHtqqiTHIFuHi9nN3g0v/y3llnRx
         P//u3ph/61x5C05qs6FmV9mDU5e56j3rY1iQQhxQFp9qs/DB/BIBQe7W+e96XbUgXtqc
         mdLA==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b="RNkh/QB0";
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=rxI50zWW;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id i11-20020a17090a974b00b0028ced82a7dcsi12424969pjw.4.2024.01.15.14.28.18
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Mon, 15 Jan 2024 14:28:19 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b="RNkh/QB0";
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=rxI50zWW;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=huwX6AGmo69Ffsg0k8FOCJ5d41UGUjQc1m6pfM52pYA=;
	b=RNkh/QB0bHMQYLWOUz2iY/p0xlWaCc3yz6yHxY4PD3VKizduF4lNfXeU8QeVix4dE4nu
	kdaB8lG2CpVO5K8C8pQmgwp8yTB4PhC1+AVxbJA7kRLtSf9aLRfc6ABuZtRL0NoYyriwbC
	XaBGNcPapNHTB28aFbYVnzqyw91oXvgGWJMsAChzVqEUY96qX4ITegyXqIVAynhyNmZOTe
	stmODE0b+/LKQA5Z1uKaWZd3/cUgbgjnmVtSvaEAy27cPI4pot64snp+BDX74JIzIIjyIB
	tdxkKlFi7rmaW/SJHpqlF8k7gdNvT8fUb1ErNrWPjm2aILl5gwe39P0YL1DOgaxQ==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=huwX6AGmo69Ffsg0k8FOCJ5d41UGUjQc1m6pfM52pYA=;
	b=rxI50zWW3tyzPa8UufsxtRNMXlENUQtfve2GdFcTSAYBvtTyYCzctjFXJzkqOmMiU3ZR
	LoQ2f5jd7udrh6LNfsTDEWprR7O/s2VwDiUXWZ3clwz4RjUEK4P7SyvarTsnVnOIoNztoX
	9O01ippyMaKPL4tmtGIjWLTDUOzX5fKr0=
Received: by filterdrecv-78db7c6dd4-q5746 with SMTP id filterdrecv-78db7c6dd4-q5746-1-65A5B17E-5
        2024-01-15 22:28:14.102438483 +0000 UTC m=+7789601.976213654
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-35 (SG) with HTTP
	id Vm7xbvkHQiynWSkB_52J-Q
	Mon, 15 Jan 2024 22:28:13.977 +0000 (UTC)
Content-Type: multipart/alternative; boundary=879fe34a7e76fa2c80741c38faca70577ff126fcf185678955d24967874b
Date: Mon, 15 Jan 2024 22:28:17 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <Vm7xbvkHQiynWSkB_52J-Q@geopod-ismtpd-35>
Subject: PRO/EDR> Shigellosis - USA (02): (Philadelphia) antimicrobial
 resistant, homelessness
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBDH4mJ47qsLFE6u7Qr=2F8E7WlhyTFqPS3GCutwl?=
 =?us-ascii?Q?c2AOsSEpDdgBqGZ7bMxoUyzxbOr2ks+9eazt=2FH7?=
 =?us-ascii?Q?rPz+3u5EZY6z8assbp5SDSdAGPhypa+bebpSYcR?=
 =?us-ascii?Q?HQbXmmj9p3Ql9Tr+4Za4p+26xwR30SHiWi3uBlM?=
 =?us-ascii?Q?+deZVCbyrEKZVmxUfKPA5mGZgnHUo7xrnQLkn9?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUhc93xcG=2F095a5S4+mt=2FG?=
 =?us-ascii?Q?uYUpctI=2FOGD2dwyi+uvm2j4FCdvuw0l9zcHM8iA?=
 =?us-ascii?Q?mojOvTXq7jOpDFFNtfsYkHQYACEW8pq1BXXqYmH?=
 =?us-ascii?Q?oGTsnt6QpE2ZV5WVqnpwfXWoLXx7+4ZoYPbk32L?=
 =?us-ascii?Q?KhEObw8sN1i9EUYWR3Su6V5cdcqu=2FDRlrEVteXf?=
 =?us-ascii?Q?A7coHOGCczWZBdgcRvgaTItOZQABh97gg+hUlV3?=
 =?us-ascii?Q?rlBhUNd7KHQ2kJp6Ejm7JSygV8lTkIVBw8aCZU3?=
 =?us-ascii?Q?haOHDgWiMuCyHhaJvAFCpjvwrOKBrD4Q54muUYA?=
 =?us-ascii?Q?7D1D2fGMruRP0aWwDFTSegODU2QOIfHa3p8rINg?=
 =?us-ascii?Q?K1xdQxNArnONDZed5QC6odSxT8KkhV+i42y031G?=
 =?us-ascii?Q?0by5HtlXf7nyWvzXh2t=2Ff+1qwbylsFRWx9LYuwm?=
 =?us-ascii?Q?OzACXkoYPm3CAK7jjeyQHSEXHkav40WsiyScv9g?=
 =?us-ascii?Q?gRb+DDbRqsuFFDEPR1UN8eCd+FC4KzGjdR4OmHq?=
 =?us-ascii?Q?UkqpqgGM437HGKF8XdbwNoPq8u0gN9Dy6eLLfiJ?=
 =?us-ascii?Q?riMTtAeDFN1n6g2GrwhyJAW8vcfLNOCgZXoH=2FxZ?=
 =?us-ascii?Q?+pfnzHSpuzcePy1TLmq74tj8Fliyeylxr9HMG+C?=
 =?us-ascii?Q?eOxBjO2NCr7Jyq8QEKtMl=2Fw10GBeZ0NL+oMU4s5?=
 =?us-ascii?Q?FqFYaJDr3jUTzIgmSdMnN+xPD+ZZj9pSDJgLnwR?=
 =?us-ascii?Q?FEQaXITcSgzz0Ejm6VmWFUmC8=2FtrJghR2jBCPWh?=
 =?us-ascii?Q?86XEKyRFF2CeefxTrSraB6Dggw=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2E6nsdN8PXu?=
 =?us-ascii?Q?9g6mj061dtYb7bNFlhfdQ40=5F3yPPqLgaSJoMDAw?=
 =?us-ascii?Q?dTAwMOuVkWvE26icxgFZye1UflIf8ligh-DuF52?=
 =?us-ascii?Q?epgApO9rIlTy8mOQvm6GXbFaZHOifphNgrOS8ZK?=
 =?us-ascii?Q?rYqMyn7AFGcU8CaqCSSvc2aRgjBuJUZL45FteK3?=
 =?us-ascii?Q?PNjeV45q8WVo8QCdw=3D=3D=2EGukNrkf7UrKfkcEqOx9?=
 =?us-ascii?Q?JK3rgNlGJsUGfHKMTJgaoHAdoMDAwdTAwMF0CSf?=
 =?us-ascii?Q?zyK82qnCl6-uvup-GlO5jp-MhdxMHzqVMv9nkpD?=
 =?us-ascii?Q?Rqth7lY4va9ohwg4QPmeCioI6ziGgXbL-eiU8nZ?=
 =?us-ascii?Q?TO03F2a8gQyQ2gEMAv9D9NLg8mrWXzeXZeE6o2Z?=
 =?us-ascii?Q?2SpxrZwbVVGdi-j9JQJqXMktjbr5f--lKdD0tY=5F?=
 =?us-ascii?Q?=5FkzZbgMZhw3u5OviGx-d5kGwNogGirISETsXQC5?=
 =?us-ascii?Q?4Ei-6j5y1Av8tKFpvq2gtvNdpmlB6oPVsWLaH10?=
 =?us-ascii?Q?8hC8Zk3him6WS0Cp6em0kKnu-j5PAYatfxkZvgW?=
 =?us-ascii?Q?eeE1kRlDVx-hrqSk=5F7xnzmtvBJTR0vyYVcgpCh3?=
 =?us-ascii?Q?VxeIxFGLLf6jqWFUKBd3LI5g2pUvJq=5F0rtDpqCR?=
 =?us-ascii?Q?eeBEjJrVNCjdglBnGhMUpnlrrAjMgSMSn5EPm1O?=
 =?us-ascii?Q?avg3SqNEsdrmlHDvNBWZ1TY6-gCiLDnRUxwzgHI?=
 =?us-ascii?Q?YqlFkb2lJxr6i1nWHbkqQpjMVMOkosoGZY469Le?=
 =?us-ascii?Q?RxGjHg7oDdCKF=5F7XPpRSBHkTyDdxO9dgVtJF0ir?=
 =?us-ascii?Q?7=5FxaeWjUu1Xk2qEjdLJ3WZiEL5nQEGtYCa9tkNU?=
 =?us-ascii?Q?SgRzy4Hp1CwWOqsnYdR-p7WKFb467BSjocIMsmN?=
 =?us-ascii?Q?7DZg5h6CjEB-YV-W9R8TlbryH4IZUyHR3vQpAb2?=
 =?us-ascii?Q?9Ti1JdI-HUBy=5FQxl95R251bIk89gKJ-7OXPvzht?=
 =?us-ascii?Q?zmeD2nJ8M-2UqlxrMLlGTt7pTkn7pkaklfTpH4p?=
 =?us-ascii?Q?HNGEG4DTc0u=5F858Zj6UyIR8slcZJTcu2OVVpLG8?=
 =?us-ascii?Q?fZ8=5FFFfyG5Q2HD0EH=5F0t9GdHSWiOPFIfnTb4mKV?=
 =?us-ascii?Q?pFuA=5F5fTvVFCpt=5FOEqnUI6czNfZp8GSniHNcGkz?=
 =?us-ascii?Q?r9obLHRA5LtLm6DjGuaVXkHdwPP2VJOc02eBHjm?=
 =?us-ascii?Q?QDnxv5eoJHbS6oYhBKbhKPcOCGlHNtBbFThz0fg?=
 =?us-ascii?Q?ToFBrZyS4dL-WNiclxNvPZJG-UZRVO8ekBMcGuM?=
 =?us-ascii?Q?9CrYz0HBmfUOlAqQi7-6=5FCIy6rBoKt935L=5F6AcG?=
 =?us-ascii?Q?ugQkAAVFRwpJRJ2-D3D3bMA=3E?=

--879fe34a7e76fa2c80741c38faca70577ff126fcf185678955d24967874b
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=us-ascii
Mime-Version: 1.0

SHIGELLOSIS - USA (02): (PHILADELPHIA) ANTIMICROBIAL RESISTANT,
HOMELESSNESS
***************************************************************************=
*
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Sun 14 Jan 2024
Source: Medical Xpress via the Philadelphia Inquirer [abridged,
edited]
<https://medicalxpress.com/news/2024-01-shigella-antibiotic-resistant-bacte=
ria-philly.html>


Shigellosis, an increasingly hard to treat bacterial infection, is on
the rise in Philadelphia, especially among people who are experiencing
homelessness or use opioids. A total of 80 cases were reported to city
health officials in October and November 2023, combined, according to
an advisory issued last month [December 2023] by the Philadelphia
Department of Health. They included 12 children who were infected. In
comparison, fewer than 10 cases were reported per month from January
through September 2023.

_Shigella_ is a bacterium that causes bloody diarrhea, fever, and
stomach pain. It passes from one person to another when small amounts
of fecal matter are ingested, which can happen when people do not wash
their hands after using the bathroom, during sex, and by drinking
dirty water. People experiencing homelessness and without access to
clean bathrooms are at higher risk of a _Shigella_ infection. Infected
patients can get well without treatment, but more serious cases can
require antibacterial drugs. Shigellosis can be fatal.

"This is more than the typical food poisoning that people experience,"
said Richard Ebright, a microbiologist at Rutgers University. "This is
a much more severe infection."

In 2023, the CDC warned of a rise in _Shigella_ strains that can evade
antibiotics. The city has not detected locally the strains of
_Shigella_ that are resistant to nearly all antibacterials. Still, lab
testing on the strains circulating in Philadelphia show that many of
the drugs that were typically used to treat the disease are often no
longer effective, the health department noted. The development means
health-care providers cannot rely on some common and easily accessible
antimicrobials, said David Hyun, the director of the antibacterial
resistance project at Pew Charitable Trusts.

"We've been gradually seeing resistance patterns going up," Hyun
said.

[Byline: Abraham Gutman]

--
Communicated by:
ProMED

[Unlike most causes of bacterial enteritis, the inoculum of _Shigella_
able to cause disease is much lower. The link to the CDC report on
resistance in shigellosis can be found at
<https://emergency.cdc.gov/han/2023/han00486.asp>.

_Shigella_ was discovered more than 100 years ago by the Japanese
microbiologist Kiyoshi Shiga, for whom the genus is named. There are 4
species: _S. boydii_, _S. dysenteriae_, _S. flexneri_, and _S.
sonnei_. _Shigella_ organisms can survive transit through the stomach
because they are less susceptible to acid than other bacteria; for
this reason, as few as 10-100 organisms can cause disease. Ingested
bacteria pass into the small intestine where they multiply; large
numbers of bacteria then pass into the colon, where they enter the
colonic cells. Given its relatively low infectious dose, transmission
can occur via contaminated food and water or via direct
person-to-person spread, including sexual practices commoner in men
who have sex with men. Humans are the only natural reservoir for the
disease.

The bacterium is the classical cause of bacterial dysentery (formerly
known as flux or the bloody flux), an inflammatory disorder of the
colon, which results in severe diarrhea containing mucus and/or blood
in the feces with fever, abdominal pain, and rectal tenesmus (pain
while passing diarrhea).

A relatively recent review on shigellosis follows:

Citation: Kotloff K L, Riddle M S, Platts-Mills J A, et al.
Shigellosis. Lancet. 2018; 391: 801-12;
<https://doi.org/10.1016/S0140-6736(17)33296-8>.
---------------------------------------------------------------------------=
-----------------------------------------
"Summary
--------
"Shigellosis is a clinical syndrome caused by invasion of the
epithelium lining the terminal ileum, colon, and rectum by _Shigella_
species. Although infections occur globally and in people of all ages,
endemic infections among children aged 1-4 years living in low-income
and middle-income settings constitute most of the disease burden. The
versatile manifestations of these highly contagious organisms range
from acute watery diarrhoea to fulminant dysentery characterised by
frequent scant bloody stools with fever, prostration, and abdominal
cramps. A broad array of uncommon, but often severe, intestinal and
extraintestinal complications can occur. Despite marked reductions in
mortality during the past 3 decades, there are roughly 164 000 annual
deaths attributable to shigellosis. Intercontinental dissemination of
multiresistant _Shigella_ strains, facilitated by travellers and men
who have sex with men, has prompted new recommendations for antibiotic
therapy. Awareness of disease burden and the emerging threats posed by
_Shigella_ have accelerated interest in development of shigella
vaccines, many of which are being tested in clinical trials." - Mod.LL

ProMED map:
Philadelphia, Pennsylvania, United States:
<https://promedmail.org/promed-post?place=3D8714243,257>]

[See Also:
Shigellosis - USA (01): (WA)
http://promedmail.org/post/20240113.8714200
2023
----
Shigellosis - USA (04): (WA)
http://promedmail.org/post/20231214.8713723
Shigellosis - USA (03): (CA) union conference, hotel
http://promedmail.org/post/20230914.8712129
Shigellosis - USA (02): (WA)
http://promedmail.org/post/20230901.8711916
Shigellosis - USA: XDR, int'l travel, MSM, CDC HAN, mostly S. sonnei,
alert http://promedmail.org/post/20230226.8708603
2022
----
Shigellosis - USA (03): (CA)
http://promedmail.org/post/20220330.8702307
Shigellosis - USA (02): (CA)
http://promedmail.org/post/20220306.8701847
Shigellosis - USA: (CA) http://promedmail.org/post/20220227.8701699
2021
----
Shigellosis - USA (06): (CA) homeless individuals
http://promedmail.org/post/20211222.8700434
Shigellosis - USA (05): (CA) homeless individuals
http://promedmail.org/post/20211113.8699654
Shigellosis - USA (04): (CA) homeless individuals
http://promedmail.org/post/20211026.8699278
Shigellosis - USA (03): (CA) homeless individuals
http://promedmail.org/post/20211012.8699003
Shigellosis - USA (02): (KS) wildlife park, non-zoonotic, RFI
http://promedmail.org/post/20210811.8587171
Shigellosis - USA: (KS) wildlife park, RFI
http://promedmail.org/post/20210630.8486452
2019
----
Shigellosis - USA: (Guam) http://promedmail.org/post/20190319.6375402
2018
----
Shigellosis, st sonnei - USA: (VT) retirement community, multidrug
resistant http://promedmail.org/post/20181107.6132342]
.................................................ll/tw/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3Dbuiw63TdH-WjMdL6_w5wfo9daGYJWSSXHMvLxcINczRoMDAwdTAwMOG1oER=
a3YAQI8D2WVuNoRKD7iGGbGr7kWZMevYZ9E8uF417rcx8tM8IY98mB8GczDO3RX_Khqm9NrsB1w=
Xph1Jb4SatVDyTs1rze84baBgoLEp2njWXFS1rWvrtXQMxnwEA4GCYCSXW_gOiuFLvLPa3Az5iQ=
bZWifUmaeJbm4ZuS6OXnibQjHfjT7gC180_5e4bPOCJAckXyM5PwiKucf_MJbPzPUG-JYj7LOuz=
nRFR1lx6bd7D6A7NKeFF0ck1UvOShb80Rtli_SykjZtUxttB_Ve7rNn_X7cJvL1RiYFhr7apW7y=
6ycykOMwTA0sWz4OgSOVQ2yARgYZLgTjCPgIXOSa59pjqfc92YlqgprWzCLNRZ0FQfxtGId3B79=
Rb09VowzLtbcSQIMr1zhyp9LEt_ruu93e4gTdZqlbOEOzH1CmP5dcjpbHV0R-NV3UZ9Hw1a_nNf=
dkdbYmAgAyw3H8jHNXWYoo2Q4D35nSVF4lAQdMm3-8ZWdpwyp_qNXOIGUwtumQ96tuFyDiDFq38=
TNVX_IB6QHwdXbydASoKc_SPDb7vQ1_Rw3zPxaiHLpbawRxMeRqTlCoY-93BYNmxKJvp3-wu-jb=
NjxsZgVMVrddJhH3TakDHly1cLLgWx0E0PaGhzrvHZgitL1xXu2WDJSS6X_QI9jKq-uBOw9xgqt=
YRUL2aSYYaqA3Bhv7q-__gbArhO95DN4Jw3XzmlFG38zd-CJf4jTrtUS0haTJaX8X-oLbpxHWS8=
whdjmGD2rRDGY3xcx_oQhSRDVFtnPUBeqHBA6LhVAFIGr4jAGKIyQm5C4KQPjL3ffeSMl7nDMoA=
Y-7neOlAn_A0O2dHPxBWMOy6PYvjpsm5zakHh8Rxr4Fv9t8olGo8BWHGS5NNCwiJmwzGYosN_jv=
dtLrg8xesHIxihfsSfyMk6tCxteg_BwNuaRt2MOTjQEVo3ycgnC7I5KxJD_Wy7xjJMwK5XQAIps=
WBtiRcsMxgJQ6UYhimh1xO0uxaB1mMCgBMV3_RvVoXdJJSOVOkkwMysuM6FCpECIYuNcZaz8vhm=
8xMbyuc2spc9d19eDveVzj96YhH30oXbq5OSxCxpIllyFzNW2I5QlZ2Jl4NSRyuQFautYMWefWU=
U2bA3iMaGrOEdlUV-k9XXsjLKQyPyw0wqzcBy3Cofjg=3D )
############################################################
############################################################

--879fe34a7e76fa2c80741c38faca70577ff126fcf185678955d24967874b
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=us-ascii
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>SHIGELLOSIS - USA (02): (PHILADELPHIA) ANTIMICROBIAL RESISTANT,<br>HO=
MELESSNESS<br>*************************************************************=
***************<br>A ProMED-mail post<br><a href=3D"https://u19268662.ct.se=
ndgrid.net/ss/c/wscE2ng5fl6JrPIt48tisIijpefK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2T=
fv3HA/430/NzFx-6CXQn6NPLcy0CSU2A/h0/5nphxr7jl_wKLoabnKt_fqXFisPyvlB6cjubLur=
NGmk">http://www.promedmail.org</a><br>ProMED-mail is a program of the<br>I=
nternational Society for Infectious Diseases<br><a href=3D"https://u1926866=
2.ct.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48tisCT5tpD4Upm3qyMCbcYSQvc/430/NzFx=
-6CXQn6NPLcy0CSU2A/h1/NyvaAn4Xop_dnctLhA26llMedEQ-ZGqzznDV766NJyg">http://w=
ww.isid.org</a><br><br>Date: Sun 14 Jan 2024=0D<br>Source: Medical Xpress v=
ia the Philadelphia Inquirer [abridged,<br>edited]=0D<br><a href=3D"https:/=
/u19268662.ct.sendgrid.net/ss/c/P7ifjHQ-88vLP93KziIlkWipyvxTEkigrsDGMZ77bRB=
r6ETS8I9vc1IgLreTc4zQFIwTb0Kjym4uklWqeVAFg_y-L7AYS0TleF3gORK3b2Ut4ZY5L5fEJe=
uEAnfwY0p2knyAzsGeTWWlDlijEzHDpA/430/NzFx-6CXQn6NPLcy0CSU2A/h2/aYL8xf6eFiRu=
pUa3IMscuczefdY0c2fbot-GLJwZ2Ts">https://medicalxpress.com/news/2024-01-shi=
gella-antibiotic-resistant-bacteria-philly.html</a>=0D<br>=0D<br>=0D<br>Shi=
gellosis, an increasingly hard to treat bacterial infection, is on<br>the r=
ise in Philadelphia, especially among people who are experiencing<br>homele=
ssness or use opioids. A total of 80 cases were reported to city<br>health =
officials in October and November 2023, combined, according to<br>an adviso=
ry issued last month [December 2023] by the Philadelphia<br>Department of H=
ealth. They included 12 children who were infected. In<br>comparison, fewer=
 than 10 cases were reported per month from January<br>through September 20=
23.=0D<br>=0D<br>_Shigella_ is a bacterium that causes bloody diarrhea, fev=
er, and<br>stomach pain. It passes from one person to another when small am=
ounts<br>of fecal matter are ingested, which can happen when people do not =
wash<br>their hands after using the bathroom, during sex, and by drinking<b=
r>dirty water. People experiencing homelessness and without access to<br>cl=
ean bathrooms are at higher risk of a _Shigella_ infection. Infected<br>pat=
ients can get well without treatment, but more serious cases can<br>require=
 antibacterial drugs. Shigellosis can be fatal.=0D<br>=0D<br>"This is more =
than the typical food poisoning that people experience,"<br>said Richard Eb=
right, a microbiologist at Rutgers University. "This is<br>a much more seve=
re infection."=0D<br>=0D<br>In 2023, the CDC warned of a rise in _Shigella_=
 strains that can evade<br>antibiotics. The city has not detected locally t=
he strains of<br>_Shigella_ that are resistant to nearly all antibacterials=
. Still, lab<br>testing on the strains circulating in Philadelphia show tha=
t many of<br>the drugs that were typically used to treat the disease are of=
ten no<br>longer effective, the health department noted. The development me=
ans<br>health-care providers cannot rely on some common and easily accessib=
le<br>antimicrobials, said David Hyun, the director of the antibacterial<br=
>resistance project at Pew Charitable Trusts.=0D<br>=0D<br>"We've been grad=
ually seeing resistance patterns going up," Hyun<br>said.=0D<br>=0D<br>[Byl=
ine: Abraham Gutman]=0D<br>=0D<br>--=0D<br>Communicated by:=0D<br>ProMED<br=
><br>[Unlike most causes of bacterial enteritis, the inoculum of _Shigella_=
<br>able to cause disease is much lower. The link to the CDC report on<br>r=
esistance in shigellosis can be found at<br><a href=3D"https://u19268662.ct=
.sendgrid.net/ss/c/u6Jy221DtLTd6phwYNECnZfcHvO-Xkk8OqKCDl4Yb9a4DbN7rDjMjjfM=
e0yYp_WWIsWNgETpiZ49DxES_KNRfw/430/NzFx-6CXQn6NPLcy0CSU2A/h3/vDq32kPiDD-DzJ=
K4yNO6WDYX-qNVR2UPV0EDz5fr_dI">https://emergency.cdc.gov/han/2023/han00486.=
asp</a>.=0D<br>=0D<br>_Shigella_ was discovered more than 100 years ago by =
the Japanese<br>microbiologist Kiyoshi Shiga, for whom the genus is named. =
There are 4<br>species: _S. boydii_, _S. dysenteriae_, _S. flexneri_, and _=
S.<br>sonnei_. _Shigella_ organisms can survive transit through the stomach=
<br>because they are less susceptible to acid than other bacteria; for<br>t=
his reason, as few as 10-100 organisms can cause disease. Ingested<br>bacte=
ria pass into the small intestine where they multiply; large<br>numbers of =
bacteria then pass into the colon, where they enter the<br>colonic cells. G=
iven its relatively low infectious dose, transmission<br>can occur via cont=
aminated food and water or via direct<br>person-to-person spread, including=
 sexual practices commoner in men<br>who have sex with men. Humans are the =
only natural reservoir for the<br>disease.=0D<br>=0D<br>The bacterium is th=
e classical cause of bacterial dysentery (formerly<br>known as flux or the =
bloody flux), an inflammatory disorder of the<br>colon, which results in se=
vere diarrhea containing mucus and/or blood<br>in the feces with fever, abd=
ominal pain, and rectal tenesmus (pain<br>while passing diarrhea).=0D<br>=0D=
<br>A relatively recent review on shigellosis follows:=0D<br>=0D<br>Citatio=
n: Kotloff K L, Riddle M S, Platts-Mills J A, et al.<br>Shigellosis. Lancet=
. 2018; 391: 801-12;<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/T=
UIVIg4PCmni5tP3Q8lzBb5MugwcowHsZrFMKbC9gdYT1d-3KaZ4zfGSimDKeKNtDgAFVobUfhOy=
VLyiwAc7rg/430/NzFx-6CXQn6NPLcy0CSU2A/h4/wEg0KwO03Z-rqGZrtbvjiaQq9vdV4kBpM5=
16__qWwVo">https://doi.org/10.1016/S0140-6736(17)33296-8</a>.=0D<br>-------=
---------------------------------------------------------------------------=
----------------------------------=0D<br>"Summary=0D<br>--------=0D<br>"Shi=
gellosis is a clinical syndrome caused by invasion of the<br>epithelium lin=
ing the terminal ileum, colon, and rectum by _Shigella_<br>species. Althoug=
h infections occur globally and in people of all ages,<br>endemic infection=
s among children aged 1-4 years living in low-income<br>and middle-income s=
ettings constitute most of the disease burden. The<br>versatile manifestati=
ons of these highly contagious organisms range<br>from acute watery diarrho=
ea to fulminant dysentery characterised by<br>frequent scant bloody stools =
with fever, prostration, and abdominal<br>cramps. A broad array of uncommon=
, but often severe, intestinal and<br>extraintestinal complications can occ=
ur. Despite marked reductions in<br>mortality during the past 3 decades, th=
ere are roughly 164 000 annual<br>deaths attributable to shigellosis. Inter=
continental dissemination of<br>multiresistant _Shigella_ strains, facilita=
ted by travellers and men<br>who have sex with men, has prompted new recomm=
endations for antibiotic<br>therapy. Awareness of disease burden and the em=
erging threats posed by<br>_Shigella_ have accelerated interest in developm=
ent of shigella<br>vaccines, many of which are being tested in clinical tri=
als." - Mod.LL<br><br>ProMED map:<br>Philadelphia, Pennsylvania, United Sta=
tes:<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/sSnCkKCWBvais3EuV=
AOvgy2WOIX7pp1nXnn4AbwuQ3Z6WbkfhqXYXU-aTMPJ8yThJPxk8d7iPOYdFr5BdFl2aA/430/N=
zFx-6CXQn6NPLcy0CSU2A/h5/z2acEbTR16yLBugvAexAS9T2kJQG8GtVE8O052sbiY4">https=
://promedmail.org/promed-post?place=3D8714243,257</a>]<br><br>[See Also:<br=
>Shigellosis - USA (01): (WA)<br>http://promedmail.org/post/20240113.871420=
0=0D<br>2023=0D<br>----=0D<br>Shigellosis - USA (04): (WA)<br>http://promed=
mail.org/post/20231214.8713723=0D<br>Shigellosis - USA (03): (CA) union con=
ference, hotel<br>http://promedmail.org/post/20230914.8712129=0D<br>Shigell=
osis - USA (02): (WA)<br>http://promedmail.org/post/20230901.8711916=0D<br>=
Shigellosis - USA: XDR, int'l travel, MSM, CDC HAN, mostly S. sonnei,<br>al=
ert http://promedmail.org/post/20230226.8708603=0D<br>2022=0D<br>----=0D<br=
>Shigellosis - USA (03): (CA)<br>http://promedmail.org/post/20220330.870230=
7=0D<br>Shigellosis - USA (02): (CA)<br>http://promedmail.org/post/20220306=
.8701847=0D<br>Shigellosis - USA: (CA) http://promedmail.org/post/20220227.=
8701699=0D<br>2021=0D<br>----=0D<br>Shigellosis - USA (06): (CA) homeless i=
ndividuals<br>http://promedmail.org/post/20211222.8700434=0D<br>Shigellosis=
 - USA (05): (CA) homeless individuals<br>http://promedmail.org/post/202111=
13.8699654=0D<br>Shigellosis - USA (04): (CA) homeless individuals<br>http:=
//promedmail.org/post/20211026.8699278=0D<br>Shigellosis - USA (03): (CA) h=
omeless individuals<br>http://promedmail.org/post/20211012.8699003=0D<br>Sh=
igellosis - USA (02): (KS) wildlife park, non-zoonotic, RFI<br>http://prome=
dmail.org/post/20210811.8587171=0D<br>Shigellosis - USA: (KS) wildlife park=
, RFI<br>http://promedmail.org/post/20210630.8486452=0D<br>2019=0D<br>----=0D=
<br>Shigellosis - USA: (Guam) http://promedmail.org/post/20190319.6375402=0D=
<br>2018=0D<br>----=0D<br>Shigellosis, st sonnei - USA: (VT) retirement com=
munity, multidrug<br>resistant http://promedmail.org/post/20181107.6132342]=
<br>.................................................ll/tw/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3Dbuiw63TdH-WjMdL6_w5wfo9daGYJWSSXHMvLxcINczRoMDAwdT=
AwMOG1oERa3YAQI8D2WVuNoRKD7iGGbGr7kWZMevYZ9E8uF417rcx8tM8IY98mB8GczDO3RX_Kh=
qm9NrsB1wXph1Jb4SatVDyTs1rze84baBgoLEp2njWXFS1rWvrtXQMxnwEA4GCYCSXW_gOiuFLv=
LPa3Az5iQbZWifUmaeJbm4ZuS6OXnibQjHfjT7gC180_5e4bPOCJAckXyM5PwiKucf_MJbPzPUG=
-JYj7LOuznRFR1lx6bd7D6A7NKeFF0ck1UvOShb80Rtli_SykjZtUxttB_Ve7rNn_X7cJvL1RiY=
Fhr7apW7y6ycykOMwTA0sWz4OgSOVQ2yARgYZLgTjCPgIXOSa59pjqfc92YlqgprWzCLNRZ0FQf=
xtGId3B79Rb09VowzLtbcSQIMr1zhyp9LEt_ruu93e4gTdZqlbOEOzH1CmP5dcjpbHV0R-NV3UZ=
9Hw1a_nNfdkdbYmAgAyw3H8jHNXWYoo2Q4D35nSVF4lAQdMm3-8ZWdpwyp_qNXOIGUwtumQ96tu=
FyDiDFq38TNVX_IB6QHwdXbydASoKc_SPDb7vQ1_Rw3zPxaiHLpbawRxMeRqTlCoY-93BYNmxKJ=
vp3-wu-jbNjxsZgVMVrddJhH3TakDHly1cLLgWx0E0PaGhzrvHZgitL1xXu2WDJSS6X_QI9jKq-=
uBOw9xgqtYRUL2aSYYaqA3Bhv7q-__gbArhO95DN4Jw3XzmlFG38zd-CJf4jTrtUS0haTJaX8X-=
oLbpxHWS8whdjmGD2rRDGY3xcx_oQhSRDVFtnPUBeqHBA6LhVAFIGr4jAGKIyQm5C4KQPjL3ffe=
SMl7nDMoAY-7neOlAn_A0O2dHPxBWMOy6PYvjpsm5zakHh8Rxr4Fv9t8olGo8BWHGS5NNCwiJmw=
zGYosN_jvdtLrg8xesHIxihfsSfyMk6tCxteg_BwNuaRt2MOTjQEVo3ycgnC7I5KxJD_Wy7xjJM=
wK5XQAIpsWBtiRcsMxgJQ6UYhimh1xO0uxaB1mMCgBMV3_RvVoXdJJSOVOkkwMysuM6FCpECIYu=
NcZaz8vhm8xMbyuc2spc9d19eDveVzj96YhH30oXbq5OSxCxpIllyFzNW2I5QlZ2Jl4NSRyuQFa=
utYMWefWUU2bA3iMaGrOEdlUV-k9XXsjLKQyPyw0wqzcBy3Cofjg=3D" target=3D"_blank" =
class=3D"Unsubscribe--unsubscribePreferences" style=3D"font-family:sans-ser=
if;text-decoration:none;">Unsubscribe Preferences</a></div><br>############=
################################################<br>#######################=
#####################################<br><br><img src=3D"https://u19268662.=
ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/430/NzFx-6CXQn6NPLcy0CSU2A/ho.g=
if" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=3D"height:1px !imp=
ortant;width:1px !important;border-width:0 !important;margin-top:0 !importa=
nt;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !impo=
rtant;padding-top:0 !important;padding-bottom:0 !important;padding-right:0 =
!important;padding-left:0 !important;"/></body>
</html>
--879fe34a7e76fa2c80741c38faca70577ff126fcf185678955d24967874b--
